Back to DRIEHAUS CAPITAL MANAGEMENT LLC

BBIO
5 quarters

Position history for DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in BRIDGEBIO PHARMA INC

DRIEHAUS CAPITAL MANAGEMENT LLC holds 1.1M shares of BBIO (BRIDGEBIO PHARMA INC), worth $85.2M as of 2026-Q1. The position was decreased (-31.8% shares). BBIO represents 0.6% of DRIEHAUS CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$85.2M

Current Shares

1.1M

Total Value Change

+$33.3M

Total Shares Change

-353,887

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
1.1M
-31.8%
$85.2M0.6%$64.53
0
2025-Q4
Increased
1.7M
+1.1%
$128.6M0.9%$75.48
43
2025-Q3
Decreased
1.7M
-1.7%
$86.3M0.6%$51.96
0
2025-Q2
Increased
1.7M
+12.7%
$73M0.6%$44.86
47
2025-Q1
New
1.5M
-
$51.9M0.5%$35.11
57

Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used